| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 101, 635-638, Copyright © 1977 by Endocrine Society
ARTICLES |
N Barden, M Lavoie, A Dupont, J Cote and JP Cote
Addition of anti-somatostatin serum to rat islets of Langerhans which had been previously maintained in organ culture for 48h, resulted in a marked stimulation of glucagon release with no change in the rate of insulin secretion during the entire 90 min period during which the secretion of both hormones was followed. Prior saturation of the anti- somatostatin serum with somatostatin prevented the stimulatory acting on glucagon release. These data strongly suggest a physiological role for endogenous somatostatin in the control of glucagon secretion.
This article has been cited by other articles:
![]() |
K. Cejvan, D. H. Coy, and S. Efendic Intra-Islet Somatostatin Regulates Glucagon Release via Type 2 Somatostatin Receptors in Rats Diabetes, May 1, 2003; 52(5): 1176 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Strowski, R. M. Parmar, A. D. Blake, and J. M. Schaeffer Somatostatin Inhibits Insulin and Glucagon Secretion via Two Receptor Subtypes: An in Vitro Study of Pancreatic Islets from Somatostatin Receptor 2 Knockout Mice Endocrinology, January 1, 2000; 141(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |